An Open Label Phase 2 Study to Assess the Pharmacokinetics of the Accordion Pill Carbidopa-Levodopa Compared to Immediate Release Carbidopa-Levodopa in Patients With Parkinson's Disease
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 19 Dec 2018
At a glance
- Drugs Levodopa/carbidopa (Primary) ; Levodopa/carbidopa
- Indications Parkinson's disease
- Focus Pharmacokinetics
- Sponsors Intec Pharma
- 19 Dec 2018 Status changed from recruiting to active, no longer recruiting, according to an Intec Pharma media release.
- 09 Nov 2018 According to an Intec Pharma media release, data are expected by the year end.
- 22 Oct 2018 Status changed from not yet recruiting to recruiting, as reported in the Intec Pharma media release.